Clinical updates, including trial initiations, enrollment status and data readouts and publications: Amryt, Arch, Astellas, Averitas, Bionic Sight, Cytodyn, D&D, Dermata, Exelixis, Forma, Gemvax, Grünenthal, Krystal, Milestone, Neoimmunetech, Rafael, Tiziana, Wave.